Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm Birth

NAActive, not recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2025

Conditions
Pregnant WomenPregnancies at Increased Risk of Preterm Birth
Interventions
DRUG

Progesterone 200 mg vaginal capsules

Participants in this group will receive daily vaginal micronized progesterone (Microgest®) of dose 200 mg for a duration of two weeks following arrested preterm labor. This micronized progesterone will be administered to assess its impact on pregnancy prolongation and changes of cervical length following arrested preterm labor.

Trial Locations (1)

60286

Dr. Soetomo General Hospital Surabaya, Surabaya

All Listed Sponsors
lead

Dr. Soetomo General Hospital

OTHER_GOV